SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/27/20 Advanced Oxygen Technologies Inc 10-Q 12/31/19 43:1.4M Electro Filings LLC/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 164K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 20K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 20K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K 16: R1 Document and Entity Information HTML 47K 33: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 91K 43: R3 Condensed Consolidated Balance Sheets HTML 39K (Parenthetical) 21: R4 Condensed Consolidated Statement of Operations and HTML 79K Other Comprehensive Income (Loss) (Unaudited) 15: R5 Consolidated Statements of Stockholders' Equity HTML 44K (Unaudited) 32: R6 Consolidated Statements of Stockholders' Equity HTML 20K (Unaudited) (Parenthetical) 42: R7 Condensed Consolidated Statements of Cash Flows HTML 61K (Unaudited) 20: R8 Organization and Line of Business HTML 20K 17: R9 Summary of Significant Accounting Policies HTML 29K 30: R10 Revenue HTML 20K 41: R11 Leases HTML 21K 23: R12 Land HTML 20K 19: R13 Related Party Transactions HTML 18K 29: R14 Notes Payable HTML 24K 40: R15 Shareholders' Equity HTML 26K 22: R16 Subsequent Events HTML 16K 18: R17 Summary of Significant Accounting Policies HTML 62K (Policies) 31: R18 Revenue (Tables) HTML 21K 39: R19 Land (Tables) HTML 19K 28: R20 Notes Payable (Tables) HTML 19K 13: R21 Organization and Line of Business (Details HTML 17K Narrative) 36: R22 Summary of Significant Accounting Policies HTML 17K (Details Narrative) 38: R23 Revenue (Details) HTML 19K 27: R24 Land (Details) HTML 18K 12: R25 Land (Details Narrative) HTML 16K 35: R26 Related Party Transactions (Details Narrative) HTML 23K 37: R27 Notes Payable (Details) HTML 32K 26: R28 Notes Payable (Details Narrative) HTML 46K 14: R29 Shareholders' Equity (Details Narrative) HTML 74K 24: XML IDEA XML File -- Filing Summary XML 68K 34: EXCEL IDEA Workbook of Financial Reports XLSX 35K 6: EX-101.INS XBRL Instance -- aoxy-20191231 XML 365K 8: EX-101.CAL XBRL Calculations -- aoxy-20191231_cal XML 92K 9: EX-101.DEF XBRL Definitions -- aoxy-20191231_def XML 190K 10: EX-101.LAB XBRL Labels -- aoxy-20191231_lab XML 375K 11: EX-101.PRE XBRL Presentations -- aoxy-20191231_pre XML 300K 7: EX-101.SCH XBRL Schema -- aoxy-20191231 XSD 66K 25: ZIP XBRL Zipped Folder -- 0001731122-20-000065-xbrl Zip 49K
EXHIBIT 31.1
CERTIFICATIONS
I, Robert Wolfe, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q for the 6 month period ended December 31, 2020 of Advanced Oxygen Technologies, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for, the periods presented in this report; |
4. | I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
(b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
(c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
(d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
(b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: January 27, 2020 | By: | /s/ Robert Wolfe | |
Robert Wolfe | |||
Chief Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
12/31/20 | None on these Dates | |||
Filed on: | 1/27/20 | |||
For Period end: | 12/31/19 | |||
List all Filings |